Bleakley Financial Group, LLC

SEC CIK: 0001936953
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

VTGN holding history

Vistagen Therapeutics, Inc. in every 13F filed by Bleakley Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VTGN overview All 13F holders of VTGN Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of VTGN by Bleakley Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−502−100.0%	Sold outConverted for a 1-for-30 split	Holders
Q1 2023	15,073	$1.88K	<0.1%	+521+3.6%	Added	Holders
Q4 2022	14,552	$1.50K	<0.1%	–	No prior filing	Holders